Disparities in allele frequencies and population differentiation for 101 disease-associated single nucleotide polymorphisms between Puerto Ricans and non-Hispanic whites
详细信息 查看全文
- 作者：Josiemer Mattei (1) (2)
Laurence D Parnell (1)
Chao-Qiang Lai (1)
Bibiana Garcia-Bailo (3)
Xian Adiconis (4)
Jian Shen (1)
Donna Arnett (5)
Serkalem Demissie (6)
Katherine L Tucker (1) (2)
Jose M Ordovas (1) (2) - 刊名：BMC Genetics
- 出版年：2009
- 出版时间：December 2009
- 年：2009
- 卷：10
- 期：1
- 全文大小：1056KB
- 参考文献：1. United States Census Bureau: United States General Demographic Characteristics: 2004 American Community Survey[der.census.gov/" class="a-plus-plus">http://factfinder.census.gov/]
2. Zsembik BA, Fennell D: Ethnic variation in health and the determinants of health among Latinos. / Soc Sci Med 2005,61(1): 53-3. dx.doi.org/10.1016/j.socscimed.2004.11.040">CrossRef
3. Hajat A, Lucas JB, Kington R: Health outcomes among Hispanic subgroups: data from the National Health Interview Survey, 1992-5. / Adv Data 2000, (310): 1-4.
4. Cleghorn GD, Nguyen M, Roberts B, Duran G, Tellez T, Alecon M: Practice-based interventions to improve health care for Latinos with diabetes. / Ethn Dis 2004,14(3 Suppl 1): S117-21.
5. Lin H, Bermudez OI, Falcon LM, Tucker KL: Hypertension among Hispanic elders of a Caribbean origin in Massachusetts. / Ethn Dis 2002,12(4): 499-07.
6. Falcon LM, Tucker KL: Prevalence and correlates of depressive symptoms among Hispanic elders in Massachusetts. / J Gerontol B Psychol Sci Soc Sci 2000,55(2): S108-16.
7. Denney JT, Krueger PM, Rogers RG, Boardman JD: Race/ethnic and sex differentials in body mass among US adults. / Ethn Dis 2004,14(3): 389-98.
8. Bermudez OI, Tucker KL: Total and central obesity among elderly Hispanics and the association with Type 2 diabetes. / Obes Res 2001,9(8): 443-51. dx.doi.org/10.1038/oby.2001.58">CrossRef
9. Tucker KL, Falcon LM, Bianchi LA, Cacho E, Bermudez OI: Self-reported prevalence and health correlates of functional limitation among Massachusetts elderly Puerto Ricans, Dominicans, and non-Hispanic white neighborhood comparison group. / J Gerontol A Biol Sci Med Sci 2000,55(2): M90-7.
10. American Diabetes Association: Total Prevalence of Diabetes &Pre-diabetes.[diabetes.org/diabetes-statistics/prevalence.jsp" class="a-plus-plus">http://www.diabetes.org/diabetes-statistics/prevalence.jsp]
11. Oquendo MA, Lizardi D, Greenwald S, Weissman MM, Mann JJ: Rates of lifetime suicide attempt and rates of lifetime major depression in different ethnic groups in the United States. / Acta Psychiatr Scand 2004,110(6): 446-51. dx.doi.org/10.1111/j.1600-0447.2004.00404.x">CrossRef
12. Martinez-Cruzado JC, Toro-Labrador G, Viera-Vera J, Rivera-Vega MY, Startek J, Latorre-Esteves M, Roman-Colon A, Rivera-Torres R, Navarro-Millan IY, Gomez-Sanchez E, / et al.: Reconstructing the population history of Puerto Rico by means of mtDNA phylogeographic analysis. / Am J Phys Anthropol 2005,128(1): 131-55. dx.doi.org/10.1002/ajpa.20108">CrossRef
13. Gonzalez Burchard E, Borrell LN, Choudhry S, Naqvi M, Tsai HJ, Rodriguez-Santana JR, Chapela R, Rogers SD, Mei R, Rodriguez-Cintron W, / et al.: Latino populations: a unique opportunity for the study of race, genetics, and social environment in epidemiological research. / Am J Public Health 2005,95(12): 2161-168. dx.doi.org/10.2105/AJPH.2005.068668">CrossRef
14. Choudhry S, Coyle NE, Tang H, Salari K, Lind D, Clark SL, Tsai HJ, Naqvi M, Phong A, Ung N, / et al.: Population stratification confounds genetic association studies among Latinos. / Hum Genet 2006,118(5): 652-64. dx.doi.org/10.1007/s00439-005-0071-3">CrossRef
15. Taioli E, Pedotti P, Garte S: Importance of allele frequency estimates in epidemiological studies. / Mutat Res 2004,567(1): 63-0. dx.doi.org/10.1016/j.mrrev.2004.06.001">CrossRef
16. Race, Ethnicity, Genetics Working Group: The use of racial, ethnic, and ancestral categories in human genetics research. / Am J Hum Genet 2005, 77: 519-32. dx.doi.org/10.1086/491747">CrossRef
17. Goddard KA, Hopkins PJ, Hall JM, Witte JS: Linkage disequilibrium and allele-frequency distributions for 114 single-nucleotide polymorphisms in five populations. / Am J Hum Genet 2000,66(1): 216-34. dx.doi.org/10.1086/302727">CrossRef
18. Ioannidis JP, Ntzani EE, Trikalinos TA: 'Racial' differences in genetic effects for complex diseases. / Nat Genet 2004,36(12): 1312-318. dx.doi.org/10.1038/ng1474">CrossRef
19. Spielman RS, Bastone LA, Burdick JT, Morley M, Ewens WJ, Cheung VG: Common genetic variants account for differences in gene expression among ethnic groups. / Nat Genet 2007,39(2): 226-31. dx.doi.org/10.1038/ng1955">CrossRef
20. Lan Q, Shen M, Garcia-Rossi D, Chanock S, Zheng T, Berndt SI, Puri V, Li G, He X, Welch R, / et al.: Genotype frequency and F ST analysis of polymorphisms in immunoregulatory genes in Chinese and Caucasian populations. / Immunogenetics 2007,59(11): 839-52. dx.doi.org/10.1007/s00251-007-0253-3">CrossRef
21. Lanfear DE, Marsh S, Cresci S, Shannon WD, Spertus JA, McLeod HL: Genotypes associated with myocardial infarction risk are more common in African Americans than in European Americans. / J Am Coll Cardiol 2004,44(1): 165-67. dx.doi.org/10.1016/j.jacc.2004.03.053">CrossRef
22. Chandalia M, Grundy SM, Adams-Huet B, Abate N: Ethnic differences in the frequency of ENPP1/PC1 121Q genetic variant in the Dallas Heart Study cohort. / J Diabetes Complications 2007,21(3): 143-48. dx.doi.org/10.1016/j.jdiacomp.2006.11.003">CrossRef
23. Pemberton TJ, Mehta NU, Witonsky D, Di Rienzo A, Allayee H, Conti DV, Patel PI: Prevalence of common disease-associated variants in Asian Indians. / BMC Genet 2008, 9: 13. dx.doi.org/10.1186/1471-2156-9-13">CrossRef
24. Myles S, Davison D, Barrett J, Stoneking M, Timpson N: Worldwide population differentiation at disease-associated SNPs. / BMC Med Genomics 2008, 1: 22. dx.doi.org/10.1186/1755-8794-1-22">CrossRef
25. Tang H, Choudhry S, Mei R, Morgan M, Rodriguez-Cintron W, Burchard EG, Risch NJ: Recent genetic selection in the ancestral admixture of Puerto Ricans. / Am J Hum Genet 2007,81(3): 626-33. dx.doi.org/10.1086/520769">CrossRef
26. Kullo IJ, Ding K: Patterns of population differentiation of candidate genes for cardiovascular disease. / BMC Genet 2007, 8: 48. dx.doi.org/10.1186/1471-2156-8-48">CrossRef
27. Olshen AB, Gold B, Lohmueller KE, Struewing JP, Satagopan J, Stefanov SA, Eskin E, Kirchhoff T, Lautenberger JA, Klein RJ, / et al.: Analysis of genetic variation in Ashkenazi Jews by high density SNP genotyping. / BMC Genet 2008, 9: 14. dx.doi.org/10.1186/1471-2156-9-14">CrossRef
28. Rockman MV, Hahn MW, Soranzo N, Zimprich F, Goldstein DB, Wray GA: Ancient and recent positive selection transformed opioid cis-regulation in humans. / PLoS Biol 2005,3(12): e387. dx.doi.org/10.1371/journal.pbio.0030387">CrossRef
29. Barreiro LB, Laval G, Quach H, Patin E, Quintana-Murci L: Natural selection has driven population differentiation in modern humans. / Nat Genet 2008,40(3): 340-45. dx.doi.org/10.1038/ng.78">CrossRef
30. Weir BS, Cardon LR, Anderson AD, Nielsen DM, Hill WG: Measures of human population structure show heterogeneity among genomic regions. / Genome Res 2005,15(11): 1468-476. dx.doi.org/10.1101/gr.4398405">CrossRef
31. Lai CQ, Tucker KL, Choudhry S, Parnell LD, Mattei J, Garcia-Bailo B, Beckman K, Burchard EG, Ordovas JM: Population admixture associated with disease prevalence in the Boston Puerto Rican health study. / Hum Genet 2009,125(2): 199-09. dx.doi.org/10.1007/s00439-008-0612-7">CrossRef
32. Tucker KL: Stress and nutrition in relation to excess development of chronic disease in Puerto Rican adults living in the Northeastern USA. / J Med Invest 2005,52(Suppl): 252-58. dx.doi.org/10.2152/jmi.52.252">CrossRef
33. Lai CQ, Arnett DK, Corella D, Straka RJ, Tsai MY, Peacock JM, Adiconis X, Parnell LD, Hixson JE, Province MA, / et al.: Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study. / Arterioscler Thromb Vasc Biol 2007,27(6): 1417-425. dx.doi.org/10.1161/ATVBAHA.107.140103">CrossRef
34. Lai CQ, Tucker KL, Parnell LD, Adiconis X, Garcia-Bailo B, Griffith J, Meydani M, Ordovas JM: PPARGC1A variation associated with DNA damage, diabetes, and cardiovascular diseases: the Boston Puerto Rican Health Study. / Diabetes 2008,57(4): 809-16. dx.doi.org/10.2337/db07-1238">CrossRef
35. National Center for Biotechnology Information[http://www.ncbi.nlm.nih.gov]
36. Livak KJ: Allelic discrimination using fluorogenic probes and the 5' nuclease assay. / Genet Anal 1999,14(5-): 143-49.
37. Liu K, Muse SV: PowerMarker: an integrated analysis environment for genetic marker analysis. / Bioinformatics 2005,21(9): 2128-129. dx.doi.org/10.1093/bioinformatics/bti282">CrossRef
38. Weir BS, Hill WG: Estimating F-statistics. / Annu Rev Genet 2002, 36: 721-50. dx.doi.org/10.1146/annurev.genet.36.050802.093940">CrossRef
39. Akey JM, Zhang G, Zhang K, Jin L, Shriver MD: Interrogating a high-density SNP map for signatures of natural selection. / Genome Res 2002,12(12): 1805-814. dx.doi.org/10.1101/gr.631202">CrossRef
40. Bamshad M, Wooding S, Salisbury BA, Stephens JC: Deconstructing the relationship between genetics and race. / Nat Rev Genet 2004,5(8): 598-09. dx.doi.org/10.1038/nrg1401">CrossRef
41. Burchard EG, Ziv E, Coyle N, Gomez SL, Tang H, Karter AJ, Mountain JL, Perez-Stable EJ, Sheppard D, Risch N: The importance of race and ethnic background in biomedical research and clinical practice. / N Engl J Med 2003,348(12): 1170-175. dx.doi.org/10.1056/NEJMsb025007">CrossRef
42. Lohmueller KE, Mauney MM, Reich D, Braverman JM: Variants associated with common disease are not unusually differentiated in frequency across populations. / Am J Hum Genet 2006,78(1): 130-36. dx.doi.org/10.1086/499287">CrossRef
43. Payami H, Zhu M, Montimurro J, Keefe R, McCulloch CC, Moses L: One step closer to fixing association studies: evidence for age- and gender-specific allele frequency variations and deviations from Hardy-Weinberg expectations in controls. / Hum Genet 2005,118(3-): 322-30. dx.doi.org/10.1007/s00439-005-0057-1">CrossRef
44. Ylonen SK, Salminen I, Lyssenko V, Virtanen SM, Groop L, Aro A, Saloranta C: The Pro12Ala polymorphism of the PPAR-gamma2 gene affects associations of fish intake and marine n-3 fatty acids with glucose metabolism. / Eur J Clin Nutr 2008,62(12): 1432-439. dx.doi.org/10.1038/sj.ejcn.1602882">CrossRef
45. Rouse I: / The Tainos: Rise and Decline of the People who Greeted Columbus New Haven: Yale University Press 1992.
46. Lin H, Bermudez OI, Tucker KL: Dietary patterns of Hispanic elders are associated with acculturation and obesity. / J Nutr 2003,133(11): 3651-657.
47. Tucker KL, Bianchi LA, Maras J, Bermudez OI: Adaptation of a food frequency questionnaire to assess diets of Puerto Rican and non-Hispanic adults. / Am J Epidemiol 1998,148(5): 507-18.
48. Tucker KL, Bermudez OI, Castaneda C: Type 2 diabetes is prevalent and poorly controlled among Hispanic elders of Caribbean origin. / Am J Public Health 2000,90(8): 1288-293. dx.doi.org/10.2105/AJPH.90.8.1288">CrossRef
49. Belle DJ, Singh H: Genetic factors in drug metabolism. / Am Fam Physician 2008,77(11): 1553-560.
50. Buzzetti R, Petrone A, Ribaudo MC, Alemanno I, Zavarella S, Mein CA, Maiani F, Tiberti C, Baroni MG, Vecci E, / et al.: The common PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity. / Eur J Hum Genet 2004,12(12): 1050-054. dx.doi.org/10.1038/sj.ejhg.5201283">CrossRef
51. Deeb SS, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen L, Kuusisto J, Laakso M, Fujimoto W, Auwerx J: A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. / Nat Genet 1998,20(3): 284-87. dx.doi.org/10.1038/3099">CrossRef
52. Frederiksen L, Brodbaek K, Fenger M, Jorgensen T, Borch-Johnsen K, Madsbad S, Urhammer SA: Comment: studies of the Pro12Ala polymorphism of the PPAR-gamma gene in the Danish MONICA cohort: homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome. / J Clin Endocrinol Metab 2002,87(8): 3989-992. dx.doi.org/10.1210/jc.87.8.3989">CrossRef
53. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, Lane CR, Schaffner SF, Bolk S, Brewer C, / et al.: The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. / Nat Genet 2000,26(1): 76-0. dx.doi.org/10.1038/79216">CrossRef
54. Ludovico O, Pellegrini F, Di Paola R, Minenna A, Mastroianno S, Cardellini M, Marini MA, Andreozzi F, Vaccaro O, Sesti G, / et al.: Heterogeneous effect of peroxisome proliferator-activated receptor gamma2 Ala12 variant on type 2 diabetes risk. / Obesity (Silver Spring) 2007,15(5): 1076-081. dx.doi.org/10.1038/oby.2007.617">CrossRef
55. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN: Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. / Nat Genet 2003,33(2): 177-82. dx.doi.org/10.1038/ng1071">CrossRef
56. Temelkova-Kurktschiev T, Hanefeld M, Chinetti G, Zawadzki C, Haulon S, Kubaszek A, Koehler C, Leonhardt W, Staels B, Laakso M: Ala12Ala genotype of the peroxisome proliferator-activated receptor gamma2 protects against atherosclerosis. / J Clin Endocrinol Metab 2004,89(9): 4238-242. dx.doi.org/10.1210/jc.2003-032120">CrossRef
57. Sparso T, Andersen G, Nielsen T, Burgdorf KS, Gjesing AP, Nielsen AL, Albrechtsen A, Rasmussen SS, Jorgensen T, Borch-Johnsen K, / et al.: The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes. / Diabetologia 2008,51(1): 70-5. dx.doi.org/10.1007/s00125-007-0865-z">CrossRef
58. Xiao J, Zhang F, Wiltshire S, Hung J, Jennens M, Beilby JP, Thompson PL, McQuillan BM, McCaskie PA, Carter KW, / et al.: The apolipoprotein AII rs5082 variant is associated with reduced risk of coronary artery disease in an Australian male population. / Atherosclerosis 2008,199(2): 333-39. dx.doi.org/10.1016/j.atherosclerosis.2007.11.017">CrossRef
59. Delgado-Lista J, Perez-Jimenez F, Tanaka T, Perez-Martinez P, Jimenez-Gomez Y, Marin C, Ruano J, Parnell L, Ordovas JM, Lopez-Miranda J: An apolipoprotein A-II polymorphism (-265T/C, rs5082) regulates postprandial response to a saturated fat overload in healthy men. / J Nutr 2007,137(9): 2024-028.
60. Roberts CG, Shen H, Mitchell BD, Damcott CM, Shuldiner AR, Rodriguez A: Variants in scavenger receptor class B type I gene are associated with HDL cholesterol levels in younger women. / Hum Hered 2007,64(2): 107-13. dx.doi.org/10.1159/000101962">CrossRef
61. Qi L, Corella D, Sorli JV, Portoles O, Shen H, Coltell O, Godoy D, Greenberg AS, Ordovas JM: Genetic variation at the perilipin (PLIN) locus is associated with obesity-related phenotypes in White women. / Clin Genet 2004,66(4): 299-10. dx.doi.org/10.1111/j.1399-0004.2004.00309.x">CrossRef
62. Chien KL, Fang WH, Wen HC, Lin HP, Lin YL, Lin SW, Wu JH, Kao JT: APOA1/C3/A5 haplotype and risk of hypertriglyceridemia in Taiwanese. / Clin Chim Acta 2008,390(1-): 56-2. dx.doi.org/10.1016/j.cca.2007.12.014">CrossRef
63. Maasz A, Kisfali P, Horvatovich K, Mohas M, Marko L, Csongei V, Farago B, Jaromi L, Magyari L, Safrany E, / et al.: Apolipoprotein A5 T-1131C variant confers risk for metabolic syndrome. / Pathol Oncol Res 2007,13(3): 243-47. dx.doi.org/10.1007/BF02893505">CrossRef
64. Szalai C, Keszei M, Duba J, Prohaszka Z, Kozma GT, Csaszar A, Balogh S, Almassy Z, Fust G, Czinner A: Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease. / Atherosclerosis 2004,173(1): 109-14. dx.doi.org/10.1016/j.atherosclerosis.2003.12.003">CrossRef
65. Wang J, Ban MR, Kennedy BA, Anand S, Yusuf S, Huff MW, Pollex RL, Hegele RA: APOA5 genetic variants are markers for classic hyperlipoproteinemia phenotypes and hypertriglyceridemia. / Nat Clin Pract Cardiovasc Med 2008,5(11): 730-37. dx.doi.org/10.1038/ncpcardio1326">CrossRef
66. Henneman P, Schaap FG, Havekes LM, Rensen PC, Frants RR, van Tol A, Hattori H, Smelt AH, van Dijk KW: Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism. / Atherosclerosis 2007,193(1): 129-34. dx.doi.org/10.1016/j.atherosclerosis.2006.05.030">CrossRef
67. Samuels ME, Forbey KC, Reid JE, Abkevich V, Bulka K, Wardell BR, Bowen BR, Hopkins PN, Hunt SC, Ballinger DG, / et al.: Identification of a common variant in the lipoprotein lipase gene in a large Utah kindred ascertained for coronary heart disease: the -93G/D9N variant predisposes to low HDL-C/high triglycerides. / Clin Genet 2001,59(2): 88-8. dx.doi.org/10.1034/j.1399-0004.2001.590205.x">CrossRef
68. Hoffer MJ, Bredie SJ, Snieder H, Reymer PW, Demacker PN, Havekes LM, Boomsma DI, Stalenhoef AF, Frants RR, Kastelein JJ: Gender-related association between the -93T-->G/D9N haplotype of the lipoprotein lipase gene and elevated lipid levels in familial combined hyperlipidemia. / Atherosclerosis 1998,138(1): 91-9. dx.doi.org/10.1016/S0021-9150(98)00007-0">CrossRef
69. Kastelein JJ, Groenemeyer BE, Hallman DM, Henderson H, Reymer PW, Gagne SE, Jansen H, Seidell JC, Kromhout D, Jukema JW, / et al.: The Asn9 variant of lipoprotein lipase is associated with the -93G promoter mutation and an increased risk of coronary artery disease. The Regress Study Group. / Clin Genet 1998,53(1): 27-3. dx.doi.org/10.1034/j.1399-0004.1998.531530106.x">CrossRef
70. Wittrup HH, Andersen RV, Tybjaerg-Hansen A, Jensen GB, Nordestgaard BG: Combined analysis of six lipoprotein lipase genetic variants on triglycerides, high-density lipoprotein, and ischemic heart disease: cross-sectional, prospective, and case-control studies from the Copenhagen City Heart Study. / J Clin Endocrinol Metab 2006,91(4): 1438-445. dx.doi.org/10.1210/jc.2005-1725">CrossRef
71. Garenc C, Couillard C, Laflamme N, Cadelis F, Gagne C, Couture P, Julien P, Bergeron J: Effect of the APOC3 Sst I SNP on fasting triglyceride levels in men heterozygous for the LPL P207L deficiency. / Eur J Hum Genet 2005,13(10): 1159-165. dx.doi.org/10.1038/sj.ejhg.5201469">CrossRef
72. Liu HK, Li XF, Zhang SZ, Ren Y, Yong X, Liu YQ, Wang CT, Chen X, Hu YM, Zhang L: Association of Sst I polymorphism in apolipoprotein C3 gene with hypertriglyceridaemia in coronary atherosclerotic heart disease and type II diabetes mellitus in Chinese population. / Yi Chuan Xue Bao 2005,32(1): 11-8.
73. Russo GT, Meigs JB, Cupples LA, Demissie S, Otvos JD, Wilson PW, Lahoz C, Cucinotta D, Couture P, Mallory T, / et al.: Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study. / Atherosclerosis 2001,158(1): 173-81. dx.doi.org/10.1016/S0021-9150(01)00409-9">CrossRef
74. Chhabra S, Narang R, Krishnan LR, Vasisht S, Agarwal DP, Srivastava LM, Manchanda SC, Das N: Apolipoprotein C3 SstI polymorphism and triglyceride levels in Asian Indians. / BMC Genet 2002, 3: 9. dx.doi.org/10.1186/1471-2156-3-9">CrossRef
75. Han T, Jiang Z, Suo G, Zhang S: Apolipoprotein B-100 gene Xba I polymorphism and cholesterol gallstone disease. / Clin Genet 2000,57(4): 304-08. dx.doi.org/10.1034/j.1399-0004.2000.570410.x">CrossRef
76. Li S, Lei ZW, Chen Z, Lin D, Ke XS, Zhong YM, Wu SF: [Relationship between apolipoprotein E and apolipoprotein B polymorphisms in youths with coronary heart disease]. / Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2003,20(3): 241-43.
77. Bernard S, Charriere S, Charcosset M, Berthezene F, Moulin P, Sassolas A: Relation between XbA1 apolipoprotein B gene polymorphism and cardiovascular risk in a type 2 diabetic cohort. / Atherosclerosis 2004,175(1): 177-81. dx.doi.org/10.1016/j.atherosclerosis.2004.03.017">CrossRef
78. Hegele RA, Connelly PW, Hanley AJ, Sun F, Harris SB, Zinman B: Common genomic variation in the APOC3 promoter associated with variation in plasma lipoproteins. / Arterioscler Thromb Vasc Biol 1997,17(11): 2753-758.
79. Martinelli N, Trabetti E, Bassi A, Girelli D, Friso S, Pizzolo F, Sandri M, Malerba G, Pignatti PF, Corrocher R, / et al.: The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study. / Atherosclerosis 2007,191(2): 409-17. dx.doi.org/10.1016/j.atherosclerosis.2006.04.009">CrossRef
80. Talmud PJ, Hawe E, Martin S, Olivier M, Miller GJ, Rubin EM, Pennacchio LA, Humphries SE: Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. / Hum Mol Genet 2002,11(24): 3039-046. dx.doi.org/10.1093/hmg/11.24.3039">CrossRef
81. Muendlein A, Saely CH, Marte T, Schmid F, Koch L, Rein P, Langer P, Aczel S, Drexel H: Synergistic effects of the apolipoprotein E epsilon3/epsilon2/epsilon4, the cholesteryl ester transfer protein TaqIB, and the apolipoprotein C3 -482 C>T polymorphisms on their association with coronary artery disease. / Atherosclerosis 2008,199(1): 179-86. dx.doi.org/10.1016/j.atherosclerosis.2007.10.030">CrossRef - 作者单位：Josiemer Mattei (1) (2)
Laurence D Parnell (1)
Chao-Qiang Lai (1)
Bibiana Garcia-Bailo (3)
Xian Adiconis (4)
Jian Shen (1)
Donna Arnett (5)
Serkalem Demissie (6)
Katherine L Tucker (1) (2)
Jose M Ordovas (1) (2)
1. Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, MA, USA
2. Friedman School of Nutrition Science and Policy Tufts University, Boston, MA, USA
3. Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
4. Genome Biology and Cell Circuits Program, Broad Institute, Cambridge, MA, USA
5. Department of Epidemiology, University of Alabama, Birmingham, Birmingham, AL, USA
6. Department of Biostatistics, School of Public Health, Boston University, Boston, MA, USA
文摘
Background Variations in gene allele frequencies can contribute to differences in the prevalence of some common complex diseases among populations. Natural selection modulates the balance in allele frequencies across populations. Population differentiation (FST) can evidence environmental selection pressures. Such genetic information is limited in Puerto Ricans, the second largest Hispanic ethnic group in the US, and a group with high prevalence of chronic disease. We determined allele frequencies and population differentiation for 101 single nucleotide polymorphisms (SNPs) in 30 genes involved in major metabolic and disease-relevant pathways in Puerto Ricans (n = 969, ages 45-5 years) and compared them to similarly aged non-Hispanic whites (NHW) (n = 597). Results Minor allele frequency (MAF) distributions for 45.5% of the SNPs assessed in Puerto Ricans were significantly different from those of NHW. Puerto Ricans carried risk alleles in higher frequency and protective alleles in lower frequency than NHW. Patterns of population differentiation showed that Puerto Ricans had SNPs with exceptional FST values in intronic, non-synonymous and promoter regions. NHW had exceptional FST values in intronic and promoter region SNPs only. Conclusion These observations may serve to explain and broaden studies on the impact of gene polymorphisms on chronic diseases affecting Puerto Ricans.